Ticker name:MDGL MADRIGAL PHARMACEUTICALS, INC.
Country: US-Sector: Healthcare, Industry: Biotechnology
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.
- CEO: William J. Sibold
- IPO: Feb 06, 2007
- Website:...igalpharma.com (open a new tab)
Market Cap 12B
Last close 513.47$
Key metrics
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 109B | 430.44$ | |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | 68B | 649.76$ | |
| 3 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 40B | 298.48$ | |
| 4 | RVMD | Revolution Medicines, Inc. | 32B | 150.33$ | |
| 5 | RPRX | Royalty Pharma plc | 31B | 53.06$ | |
| 6 | UTHR | UNITED THERAPEUTICS Corp | 24B | 563.93$ | |
| 7 | INSM | INSMED Inc | 23B | 107.91$ | |
| 8 | ROIV | Roivant Sciences Ltd. | 23B | 32.41$ | |
| 9 | INCY | INCYTE CORP | 19B | 97.08$ | |
| 10 | MRNA | Moderna, Inc. | 19B | 48.12$ | |
| 11 | GMAB | GENMAB A/S | 17B | 27.21$ | |
| 12 | JAZZ | Jazz Pharmaceuticals plc | 15B | 239.01$ | |
| 13 | ASND | Ascendis Pharma A/S | 15B | 241.34$ | |
| 14 | SMMT | Summit Therapeutics Inc. | 14B | 17.89$ | |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13B | 68.22$ | |
| 16 | EXEL | EXELIXIS, INC. | 13B | 49.9$ | |
| 17 | IONS | IONIS PHARMACEUTICALS INC | 12B | 75.06$ | |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12B | 230.62$ | |
| 19 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | 12B | 513.47$ | |
| 20 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 11B | 77.14$ |